BIORQ — Biora Therapeutics Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $35.40m
- $0.00m
Biora Therapeutics Inc expected to post a loss of $1.60 a share - Earnings Preview
Brief: Biora Therapeutics Announces New Patents Covering BioJet Systemic Oral Delivery Platform
Brief: Biora Therapeutics Completed Agreement With Diagnostics Company For Sale Of Legacy Assets Related To Biora's Former Diagnostics Business
Brief: Biora Therapeutics Inc Awarded Patents For Its Navicap
Brief: Biora Therapeutics Announces $8 Mln Registered Direct Offering
Brief: Biora Therapeutics Receives Compliance Letter From Nasdaq
Brief: Biora Therapeutics Reports First Quarter 2023 Results
Biora Therapeutics Inc expected to post a loss of $1.75 a share - Earnings Preview
Biora Therapeutics Inc expected to post a loss of $1.75 a share - Earnings Preview
Brief: Biora Therapeutics Inc Says On April 4, Received Formal Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq
Biora Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Brief: Biora Therapeutics Inc Reports Net Loss Per Share Was $1.64 For Three Months Ended December 31, 2022
Biora Therapeutics Inc expected to post a loss of $1.44 a share - Earnings Preview
Biora Therapeutics Inc expected to post a loss of $1.44 a share - Earnings Preview
Brief: Biora Therapeutics Says Does Not Hold Cash Deposits Or Securities At Silicon Valley Bank
Brief: Biora Therapeutics Announces Improved Bioavailability Results For Its Systemic Delivery Platform
Brief: Biora Therapeutics Inc Receives Notice Of Delisting From Nasdaq
Brief: Biora Therapeutics Receives Pre-Ind Feedback From FDA And Provides Update On Key Programs For 2023
U.S. STOCKS ON THE MOVE-Dynagas, Disc Medicine, Walmart